XCE Tirzepatide 10mg Wholesale for Research - High Purity 99% CAS 2023788-19-2

XCE tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research applications. This synthetic peptide demonstrates superior efficacy in glucose control and weight management compared to single-receptor agonists.

The compound appears as a white powder with >99% purity (refer to Certificate of Analysis). As a dual agonist, XCE tirzepatide exhibits greater affinity for GIP receptors while maintaining significant activity at GLP-1 receptors. This unique mechanism contributes to enhanced glycemic control in research models.

Research indicates that XCE tirzepatide mimics natural GIP activity at GIP receptors while simultaneously activating GLP-1 pathways. This dual action results in glucose-dependent insulin secretion and glucagon suppression, making it a valuable compound for metabolic disorder studies.

For optimal preservation, XCE tirzepatide should be stored in a cool, dry, dark environment at 0-4°C for short-term use or -20°C for long-term storage. The product maintains stability for >2 years when stored properly under recommended conditions.

Note: This product is intended for research purposes only. Not for human consumption. Researchers should handle all peptide compounds with appropriate laboratory safety protocols.